Current Concepts

Pharmacologic Management of Raynauds Phenomenon

Authors: T WAYNE DAY MD, FORTUNATA MENDOZA MD

Abstract

ABSTRACT: Raynauds phenomenon (RP) represents a wide spectrum of disease activity. Specific pharmacologic therapy, when indicated, should be based upon the clinicians understanding of drug effectiveness and side effects. We present an update of currently available pharmacologic agents being used for RP and review the effectiveness and side effects of these drugs.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References